Hutan Ashrafian, M.D., Ph.D, M.B.A., Interim Chief Medical Officer of Harbinger Health, presents at NextGenDx Conference, August 2024. Harbinger Health is focused on revolutionizing cancer screening with the aim of reducing the fear surrounding cancer through early detection. The company’s goal is to pioneer the cancer testing field by addressing challenges across the cancer continuum, starting with early-stage screening.
Key areas of presentation include:
- Performance, Access, and Clinical Informativeness
- Biological Foundations
- Multi-Tier Testing Approach
- Future Vision
- Leadership and Commitment
This test is not yet approved by the FDA or payer covered